<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7277397\results\search\drug\results.xml">
  <result pre="3.1. Therapeutic Agents Among therapeutics, the use of protease inhibitors" exact="lopinavir" post="and ritonavir as a combination therapy with other antiretroviral"/>
  <result pre="Agents Among therapeutics, the use of protease inhibitors lopinavir and" exact="ritonavir" post="as a combination therapy with other antiretroviral agents for"/>
  <result pre="in marmosets with a MERS-like disease [85]. In comparison to" exact="mycophenolate mofetil" post="(MFF), the treatment showed improved clinical, radiological and pathological"/>
  <result pre="recent COVID-19 pandemic, a clinical trial on 99 patients receiving" exact="lopinavir" post="and ritonavir were compared to 100 patients subjected to"/>
  <result pre="pandemic, a clinical trial on 99 patients receiving lopinavir and" exact="ritonavir" post="were compared to 100 patients subjected to standard care."/>
  <result pre="analogues were designed based on the acrylic sugar scaffold of" exact="acyclovir" post="[90]. One compound displayed selective antiviral activity against HCoV-NL63"/>
  <result pre="symptoms in two weeks. In another approach, the guanosine analogue" exact="ribavirin" post="was administered together with interferon-Î±2a in adult patients with"/>
  <result pre="ventilation support [92]. The study demonstrated that patients treated with" exact="ribavirin" post="and interferon-Î±2a showed a significantly improved survival rate at"/>
  <result pre="of treatment compared to the control group of patients. The" exact="adenosine" post="nucleoside analogue remdesivir has proven efficient for inhibition of"/>
  <result pre="load [97]. Neuraminidase inhibitors such as zanamivir, laninamivir, oseltamivir and" exact="peramivir" post="have demonstrated potency against most influenza strains [98]. In"/>
  <result pre="[98]. In this context, the neuraminidase inhibitors oseltamivir (Tamiflu) and" exact="zanamivir" post="(Relenza) were tested for inhibition of cytopathic effects of"/>
  <result pre="not against SARS-CoV [90] FIP Successful treatment of FIP [91]" exact="Ribavirin" post="MERS-CoV Improved survival at 14 days [92] Remdesivir HCoV-OC43,"/>
  <result pre="effect of the widely used antimalarial and auto-immune disease drug" exact="chloroquine" post="on coronaviruses [96]. Chloroquine blocks virus infection and interferes"/>
  <result pre="used antimalarial and auto-immune disease drug chloroquine on coronaviruses [96]." exact="Chloroquine" post="blocks virus infection and interferes with the glycosylation of"/>
  <result pre="glycosylation of cellular receptors of SARS-CoV [110]. The application of" exact="chloroquine" post="for COVID-19 patients has been justified by its common"/>
  <result pre="locals [111]. However, as indications of severe side effects of" exact="chloroquine" post="use have been reported, hydroxychloroquine, possessing a similar antiviral"/>
  <result pre="have been reported, hydroxychloroquine, possessing a similar antiviral potency to" exact="chloroquine" post="but a safer clinical profile, should be considered [112]."/>
  <result pre="viral load in comparison to control patients [103]. Addition of" exact="azithromycin" post="further significantly improved the efficiency of virus elimination. Despite"/>
  <result pre="elimination. Despite the small sample size, the study indicated that" exact="hydroxychloroquine" post="treatment was associated with a significant viral load reduction"/>
  <result pre="mechanical ventilation and had been treated with antiviral agents and" exact="methylprednisolone" post="showed a normalized body temperature within 3â€&quot;4 days and"/>
  <result pre="earlier [106]. Although the study indicated some therapeutic effect of" exact="hydroxychloroquine" post="and at least 80 trials on chloroquine, hydroxychloroquine, or"/>
  <result pre="Chinese trial in more than 100 patients demonstrated superiority of" exact="chloroquine" post="phosphate compared to control treatment in inhibition of pneumonia"/>
  <result pre="in a placebo-controlled randomized trial of two different doses of" exact="hydroxychloroquine" post="in 62 patients with radiological conformation of pneumonia, but"/>
  <result pre="reported and the trial was terminated prematurely [175]. Supporters of" exact="hydroxychloroquine" post="have referred to the history of wide and safe"/>
  <result pre="history of wide and safe use of the drug. However," exact="hydroxychloroquine" post="will potentially expose patients to serious cutaneous adverse reactions"/>
  <result pre="[176], hepatic failure [177] and ventricular arrhythmias when co-administered with" exact="azithromycin" post="[178]. In the context of lopinavir/ritonavir, a randomized, controlled,"/>
  <result pre="frequent in the standard-care group. The Efficacy of Lopinavir Plus" exact="Ritonavir" post="and Arbidol against Coronavirus Infection (ELACOI) single-blind randomized controlled"/>
  <result pre="from Middle East respiratory syndrome coronavirusJ. Biol. Chem.202010.1074/jbc.AC120.01305632094225 96.WangM.CaoR.ZhangL.YangX.LiuJ.XuM.ShiZ.HuZ.ZhongW.XiaoG.Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in"/>
  <result pre="2020) 171.Available online: www.theguardian.com/world/2020/apr/23/high-hopes-drug-for-covid-19-treatment-failed-in-full-trial(accessed on 30 April 2020) 172.FernerR.E.AronsonJ.K.Chloroquine and" exact="hydroxychloroquine" post="in COVID-19BMJ2020369m143210.1136/bmj.m143232269046 173.GaoJ.TianZ.YangX.Breakthrough: Chloroquine phosphate has shown apparent efficacy"/>
  <result pre="on 30 April 2020) 172.FernerR.E.AronsonJ.K.Chloroquine and hydroxychloroquine in COVID-19BMJ2020369m143210.1136/bmj.m143232269046 173.GaoJ.TianZ.YangX.Breakthrough:" exact="Chloroquine" post="phosphate has shown apparent efficacy in treatment of COVID-19"/>
  <result pre="of COVID-19 associated pneumonia in clinical studiesBiosci. Trends202014727310.5582/bst.2020.0104732074550 174.ChenZ.HuJ.ZhangZ.JiangS.HanS.YanD.ZhuangR.HuB.ZhangZ.Efficacy of" exact="hydroxychloroquine" post="in patients with COVID-19: Results of a randomized clinical"/>
  <result pre="of a randomized clinical trial. Version 2medRxiv202010.1101/2020.03.22.20040758 175.YanD.ZhangZ.Therapeutic Effect of" exact="Hydroxychloroquine" post="on Novel Coronavirus Pneumonia (COVID-19)Chinese Clinical Trials RegistryAvailable online:"/>
 </snippets>
</snippetsTree>
